Histologix is a leading provider of professional histology services and contract histopathology in a range of species from early discovery and regulatory preclinical toxicology through to clinical trials. Our team is experienced in taking samples from wet or frozen tissue through to slide, ensuring optimum presentation of regions of interest.
At HistologiX, no biomarker is too much trouble. Working with a proactive and flexible approach, we’re able to accommodate novel targets as well as those already well defined. We can advise on and source appropriate antibody and control tissue for your species and tissue of interest, or work with your own. With a combination of experienced scientists and a wide range of automated platforms, we pride ourselves on developing both chromogenic and immunofluorescent assays with outstanding standardisation and repeatability.
Using our Hamamatsu NanoZoomer v2 and Zeiss Axioscan Z1 HistologiX can provide brightfield and fluorescent digital scanning services.
At HistologiX we offer a range of optimised IHC/IF Immuno-oncology (IO) biomarker assays. These are used to assess the complex tumour microenvironment in tissues from preclinical models through to clinical patient samples. Coupled with the gold standard quantitative image analysis tools, we provide valuable immunological insight into tumour immune processes.
With 100+ years of combined experience, we offer Good Laboratory Practice (GLP) Tissue Cross Reactivity (TCR) studies for your biotherapeutic on a range of human tissues suitable for Investigational New Drug (IND) and Clinical Trials Application submissions.
As a long established, GCP compliant organisation with a wealth of experience in all things histology and immunohistochemistry, HistologiX are well placed to assist with your clinical trial needs, from study inception to delivery of results.
As a GLP accredited company, we undertake histology for preclinical toxicological studies for all species in-line with recognised industry standards.